A drug-drug interaction represents a specific type of adverse drug reaction, and the risk of druginteractions is proportional to the number of drugs taken. However, although potential drug-drug interactions may affect 40-65% of all hospitalized patients, the clinical consequences of these drug interactions are highly variable, and adverse effect rarely occur [5] .
The significance and appropriate management of DDIs is a continuously evolving issue for providers. Research using prescription databases can contribute to greater understanding of clinically important potential DDIs; however, only a few studies have examined clinically important DDIs in the outpatient setting, and even fewer studies have identified patients at risk for such DDIs [6] [7] [8] [9] [10] . Despite outpatients receiving drug pairs with a high potential for adverse interactions, the rate of occurrence of clinical drug interaction events was low [11] . The relative importance of drug interactions as a clinical problem remains unclear. Screening programs that do more than simply identify large numbers of patients who receive potentially interacting drug combinations without indicating which subpopulations of these individuals are likely to be harmed by the drugs have not yet been developed [12] .
The study was done in three pharmacies within a 200 meter distance of each other. The doctors were from general practices located near these pharmacies. The doctors involved were made aware of the study but data were collected without their knowledge. All 500 prescriptions are collected during the five-month study period.
A pilot study was done in the three community pharmacies to analyze the DDIs in out-patient prescriptions. Required numbers of prescriptions were collected from the community pharmacist based pharmacy with the permission of pharmacy directors and patients. Objective of the study was explained to the patients for collecting the prescriptions. Prescriptions are collected alternatively for the combinations of mixed data's during the study period.
All collected prescriptions from the three pharmacies were analyzed during the study period. The collected prescriptions from three pharmacies were thoroughly assessed for the presence of drug interactions. (7) out of 89 prescriptions, fever/pain 7.08% (9) out of 127 prescriptions and other prescriptions 14.28% (3) out of 21 prescriptions, more over arthritis and tuberculosis diseases prescriptions shows 0% interactions (Table 3 ).
In addition, with the patient's permission, the pharmacist may call the physician to get essential information about the prescriptions to rectify the The overall analysis of total prescription (500) shows that 12.8% having drug interactions and 87.2% having no drug interaction. Out of 500 prescriptions, the Moderate drug interactions were 10.2%, severe were 2.6% and contraindication were 0%. The major types were Moderate type of drug interactions. Indian Journal of Pharmaceutical Sciences September -October 2011 events. Many drug interactions can be avoided or managed safely from the pharmacist side by assessing possible drug interaction in case of multiple therapies, providing patient counseling on the use of prescription and nonprescription medication, disease state(s) and the safety of concurrent use of herbal products. Preventing and/or managing drug interactions will be more likely to occur when the pharmacist takes time and utilizes and adequate patient data base.
